Salivary Gland Pathology. Группа авторов

DW, Foshag LJ, Essner R et al. 1999. Parotid region lymphatic mapping and sentinel lymphadenopathy for cutaneous melanoma. Ann Surg Oncol 6(2):150–154.

      70 Otsuka H, Graham M, Kogame M, Nishitani H. 2005. The impact of FDG‐PET in the management of patients with salivary gland malignancy. Ann Nucl Med 19(8):691–694.

      71 Patel R, Carlos R, Midia M, Mukherji S. 2004. Apparent diffusion coefficient mapping of the normal parotid gland and parotid involvement in patients with systemic connective tissue disorders. Am J Neuroradiol 25:16–20.

      72 Patz E, Lowe V, Hoffman J et al. 1993. Focal pulmonary abnormalities: Evaluation with F‐18 fluorodeoxyglucose PET scanning. Radiology 188:487–490.

      73 Roh J, Ryu C, Choi S et al. 2007. Clinical utility of 18F‐FDG PET for patients with salivary gland malignancies. J Nucl Med 48:240–246.

      74 Rumboldt Z, Al‐Okkaili R, Deveikis J. 2005. perfusion CT for head and neck tumors: A pilot study. Am J Neuroradiol 26:1178–1185.

      75 Schoder H, Yusuf E, Chao K et al. 2004. Clinical implications of different image reconstruction parameters for interpretation of whole‐body PET studies in cancer patients. J Nucl Med 45:559–566.

      76 Shah G. 2002. MR imaging of salivary glands. Mag Reson Clin N Am 10:631–662.

      77 Shah G, Fischbein N, Patel R, Mukherji S. 2003. Newer MR imaging techniques for head and neck. Magn Reson Clin N Am 11:449–469.

      78 Sheedy S, Welker K, Delone D, Gilbertson J. 2006. CNS metastases of carcinoma ex pleomorphic adenoma of the parotid gland. Am J Neuroradiol 27:1483–1485.

      79 Shimizu K, Iwai H, Ikeda K et al. 2005. Intraparotid facial nerve schwannoma: A report of five cases and an analysis of MR imaging results. Am J Neuroradiol 26:1328–1330.

      80 Sigal R, Monnet O, De Baere T et al. 1992. Adenoid cystic carcinoma of the head and neck: Evaluation with MR imaging and clinical‐pathologic correlation in 27 patients. Radiology 184:95–101.

      81 Sobrino‐Guijarro B, Cascarini L, Lingam RK. 2013. Advances in imaging of obstructed salivary gland can improve diagnostic outcomes. Oral Maxillofac Surg 17:11–19.

      82 Sokoloff L. 1961. Local Cerebral Circulation at Rest and During Altered Cerebral Activity Induced by Anesthesia or Visual Stimulation. In: S.S. Kety, J. Elkes (eds.) The Regional Chemistry, Physiology and Pharmacology of the Nervous System. Oxford, Pergamon Press, pp. 107–117.

      83 Sokoloff L. 1986. Cerebral circulation, energy metabolism, and protein synthesis: General characteristics and principles of measurement. In: M. Phelps, J. Mazziotta, H. Schelbert (eds.) Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart. Raven Press, pp. 1–71.

      84 Som P, Curtin H (eds.). 1996. Head and Neck Imaging, 3rd edn. Mosby‐Year Book Inc, pp. 823–914.

      85 Som P, Brandwein M, Silver A. 1995. Nodal inclusion cysts of the parotid gland and parapharyngeal space: A discussion of lymphoepithelial, AIDS‐related parotid and branchial cysts, cystic Warthin's tumors, and cysts in Sjogren's syndrome. Laryngoscope 105(10):1122–1128.

      86 Stahl A, Dzewas B, Schwaige W, Weber W. 2002. Excretion of FDG into saliva and its significance for PET imaging. Nuklearmedizin 41:214–216.

      87 Su Y, Liao G, Kang Z, Zou Y. 2006. Application of magnetic resonance virtual endoscopy as a presurgical procedure before sialoendoscopy. Laryngoscope 116:1899–1906.

      88 Sugai S. 2002. Mucosa‐associated lymphoid tissue lymphoma in Sjogren's syndrome. AJR 179:485–489.

      89 Suh J, Abenoza P, Galloway H et al. 1992. Peripheral (extracranial) nerve tumors: Correlation of MR imaging and histologic findings. Radiology 183:341–346.

      90 Sumi M, Izumi M, Yonetsu K, Nakamura T. 1999a. Sublingual gland: MR features of normal and diseased states. AJR 172(3):717–722.

      91 Sumi M, Izumi M, Yonetsu K, Nakamura T. 1999b. The MR imaging assessment of submandibular gland sialoadenitis secondary to sialolithiasis: Correlation with CT and histopathologic findings. Am J Neuroradiol 20:1737–1743.

      92 Sumi M, Yamada T, Takagi Y, Nakamura T. 2007. MR imaging of labial glands. Am J Neuroradiol 28:1552–1556.

      93 Takagi Y, Sumi M, Sumi T et al. 2005a. MR microscopy of the parotid glands in patients with Sjogren's syndrome: Quantitative MR diagnostic criteria. Am J Neuroradiol 26:1207–1214.

      94 Takagi Y, Sumi M, Van Cauteren M, Nakamura T. 2005b. Fast and high resolution MR sialography using a small surface coil. J Magn Reson Imaging 22:29–37.

      95 Takahashi N, Okamoto K, Ohkubo M, Kawana M. 2005. High‐resolution magnetic resonance of the extracranial facial nerve and parotid duct: Demonstration of the branches of the intraparotid facial nerve and its relation to parotid tumours by MRI with a surface coil. Clin Radiol 60:349–354.

      96 Takashima S, Takeuchi N, Morimoto S et al. 1991. MR imaging of Sjogren's syndrome: Correlation with sialography and pathology. J Comput Assist Tomogr 15(3):393–400.

      97 Takashima S, Tomofumi N, Noguchi Y et al. 1992. CT and MR appearances of parotid pseudotumors in Sjogren's syndrome. J Comput Assist Tomogr 16(3):376–383.

      98 Tanaka T, Ono K, Habu M et al. 2007. functional evaluation of the parotid and submandibular glands using dynamic magnetic resonance sialography. Dentom Radiol 36:218–223.

      99 Tatsumi M, Engles J, Ishimori T et al. 2004. Intense 18F‐FDG uptake in Brown fat can be reduced pharmacologically. J Nucl Med 45:1189–1193.

      100 Thoeny H. 2007. Imaging of Salivary gland tumors. Cancer Imaging 7:52–62.

      101 Tonami H, Munetaka M, Yokata H et al. 2002. Mucosa‐associated lymphoid tissue lymphoma in Sjogren’s syndrome: Initial and follow‐up imaging features. AJR 179:485–489.

      102 Uchida Y, Minoshima S, Kawata T et al. 2005. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med 30:170–176.

      103 Wan Y, Chan S, Chen Y. 2004. Ultrasonography‐guided core‐needle biopsy of parotid gland masses. Am J Neuroradiol 25:1608–1612.

      104 Wang Y, Chiu E, Rosenberg J, Gambhir S. 2007. Standardized uptake value atlas: Characterization of physiological 2‐deoxy‐2‐[18F]fluoro‐D‐glucose uptake in normal tissues. Mol Imaging Biol 9(2):83–90.

      105 Warburg O. 1925. Uber den Stoffwechsel der Carcinom‐Zelle. Klin Wochenschr 4:534–536.

      106 White D, Davidson H, Harnsberger H et al. 2001. Accessory salivary tissue in the mylohyoid boutonnière: A clinical and radiologic pseudolesion of the oral cavity. Am J Neuroradiol 22:406–412.

      107 Witt BL, Schmidt RL. 2014. Ultrasound‐guided core needle biopsy of salivary gland lesions: A systematic review and meta‐analysis. Laryngoscope 124:695–700.

      108 Wong K, Ahuja A, King A et al. 2004. Vascular lesion in the parotid gland in adult patients: Diagnosis with high‐resolution ultrasound and MRI. British J Radiol 77:600–606.

      109 Yabuuchi H, Fukuya T, Tajima T et al. 2003. Salivary gland tumors: Diagnostic value of gadolinium enhanced dynamic MR imaging with histopathologic correlation. Radiology 226:345–354.

      110 Yerli H, Aydin E, Coskum M et al. 2007. Dynamic multislice CT of parotid gland. J Comput Assist Tomogr 31(2):309–316.

Chapter 3 Infections of the Salivary Glands

       Outline

        Introduction

        General Considerations